Discontinued Operations - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jul. 28, 2023 |
May 11, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Consideration on acquisition transferred | $ 8,000 | |||||
Research and Development Expense | $ 105 | $ 339 | $ 149 | $ 911 | ||
Tisento Therapeutics Holdings Inc | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Equity securities, percentage | 10.00% | |||||
Tisento Therapeutics Holdings Inc | Discontinued Operations | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Consideration on acquisition transferred | $ 8,000 | |||||
Research and Development Expense | $ 2,400 | |||||
Equity securities, percentage | 10.00% |